XM không cung cấp dịch vụ cho cư dân của Mỹ.
S
S

Stryker


Tin tức

Teleflex beats quarterly profit estimates on robust medical devices demand

Teleflex beats quarterly profit estimates on robust medical devices demand Oct 31 (Reuters) - Surgical equipment maker Teleflex TFX.N reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices. Robust demand for non-urgent procedures, especially among older adults, have kept investor expectations heightened around the performance of medical device makers over the past year.
S
T

Implant maker Zimmer Biomet lowers full-year profit forecast

Implant maker Zimmer Biomet lowers full-year profit forecast Oct 30 (Reuters) - Hip implant maker Zimmer Biomet ZBH.N lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations. Zimmer Biomet said in September it had to replace its enterprise resource planning (ERP) system due to "usual glitches".
S
Z

U.S. Agilon Health, Alphabet, Crocs

U.S. RESEARCH ROUNDUP-Agilon Health, Alphabet, Crocs Oct 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agilon Health, Alphabet and Crocs, on Wednesday. HIGHLIGHTS * Agilon Health Inc AGL.N : Citigroup cuts to sell from neutral * Alphabet Inc GOOGL.O : Seaport Research Partners raises to buy from neutral * Crocs Inc CROX.O : Raymond James cuts to market perform from outperform * Leggett & Platt Inc LEG.N : Piper
A
B
C
G
I
M
Q
V
V
A
E
E
S
U
A
A
F
L
R

Stryker Corp reports results for the quarter ended in September 30 - Earnings Summary

Stryker Corp reports results for the quarter ended in September 30 - Earnings Summary Stryker Corp SYK.N reported quarterly adjusted earnings of $2.87​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.46. The mean expectation of twenty eight analysts for the quarter was for earnings of $2.77 per share.
S

Stryker raises annual profit forecast on robust demand for medical, surgical devices

Stryker raises annual profit forecast on robust demand for medical, surgical devices Oct 29(Reuters) - Stryker Corp SYK.N slightly raised its annual profit forecast on Tuesday, banking on strong demand for its medical and surgical devices and healthy procedural volumes. Shares of the Kalamazoo, Michigan-based company rose 3.3% to $367, in after-market hours.
S

Stryker Q3 Adjusted EPS USD 2.87 Vs. IBES Estimate USD 2.77

BRIEF-Stryker Q3 Adjusted EPS USD 2.87 Vs. IBES Estimate USD 2.77 Oct 29 (Reuters) - Stryker Q3 adjusted gross margin 64.5%. Q3 adjusted EBIT margin 24.7% Q3 adjusted net income USD 1,100 million vs. IBES estimate USD 1,070 million Q3 EPS USD 2.16 Q3 revenue USD 5,500 million vs. IBES estimate USD 5,373 million Q3 net income USD 834 million outlook
S

Election-agitated Treasuries meet megacap earnings

MORNING BID AMERICAS-Election-agitated Treasuries meet megacap earnings A look at the day ahead in U.S. and global markets from Mike Dolan Even as public borrowing estimates were shaved on Monday, U.S. Treasury yields continue to probe three-month highs as markets lean toward a win for Donald Trump in next week's election and a possible clean sweep in Congress for his Republican party.
E
G
G
H
I
M
M
P
P
U
V
A
J
U
U
U
U
E
E
R
S
D
B

Hurricane-related IV fluid shortage could hurt medical device makers (Oct 17)

CORRECTED-Hurricane-related IV fluid shortage could hurt medical device makers (Oct 17) Corrects paragraph 3 in Oct. 17 story to say Baxter expects to meet 90% to 100% of allocation for certain products, not all products. The story was previously refiled to correct dateline By Manas Mishra and Christy Santhosh Oct 17 (Reuters) - A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devic
U
H
S

Treace Files Patent Infringement And Unfair Competition Suit To Protect Lapiplasty Bunion Technology

BRIEF-Treace Files Patent Infringement And Unfair Competition Suit To Protect Lapiplasty Bunion Technology Oct 14 (Reuters) - Treace Medical Concepts Inc TMCI.O : TREACE FILES PATENT INFRINGEMENT AND UNFAIR COMPETITION SUIT TO PROTECT LAPIPLASTY® BUNION TECHNOLOGY TREACE MEDICAL CONCEPTS INC - FILES LAWSUIT AGAINST STRYKER AND ITS SUBSIDIARY WRIG
S

Stryker Completes Acquisition Of Nico Corporation

BRIEF-Stryker Completes Acquisition Of Nico Corporation Sept 20 (Reuters) - Stryker Corp SYK.N : STRYKER COMPLETES ACQUISITION OF NICO CORPORATION, EXPANDING MINIMALLY INVASIVE SOLUTIONS FOR BRAIN TUMOR REMOVAL AND STROKE CARE Source text for Eikon: ID:nPnSMmzca Further company coverage: SYK.N
S

Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing

BRIEF-Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing Sept 4 (Reuters) - Stryker Corp SYK.N : STRYKER FILES FOR OFFERING OF € DENOMINATED NOTES, SIZE NOT DISCLOSED - FILING Source text for Eikon: [ID:n0001193125-24-212577] Further company coverage: SYK.N
S

U.S. STOCKS NetEase, Wolfspeed, B. Riley

BUZZ-U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
N
S
U
U
U
E
S
A

U.S. STOCKS Evogene, Stryker, Opera

BUZZ-U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
B
I
N
U
U
U
E
S
A

Stryker rises on deal to acquire Vertos Medical

BUZZ-Stryker rises on deal to acquire Vertos Medical ** Shares of medical device maker Stryker SYK.N rise 1.1% to $348.86 ** Co says it would acquire privately held Vertos Medical to expand its minimally invasive pain management portfolio ** Deal gives SYK access to Vertos' minimally invasive treatment for chronic lower back pain caused by lumbar s
S

Stryker to acquire Vertos Medical

BRIEF-Stryker to acquire Vertos Medical Aug 22 (Reuters) - Stryker Corp SYK.N : STRYKER ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE VERTOS MEDICAL, INC., EXPANDING INTERVENTIONAL PAIN MANAGEMENT SOLUTIONS STRYKER: CO & VERTOS MEDICAL WILL CONTINUE TO OPERATE AS SEPARATE ENTITIES & PROCEED WITH BUSINESS AS USUAL UNTIL DEAL CLOSES Source text for Eikon
S

Russian commander says Ukraine's forces pushing along the border front

UPDATE 1-Russian commander says Ukraine's forces pushing along the border front Russia evacuates district in Kursk Russian commander: one village taken back from Ukraine Ukrainian forces are pushing along the Kursk front Ukraine says its advance is 'going well' Intense fighting on other parts of front Russia shows U.S.-made Stryker being destroyed in Russia Adds Russia pushing out Ukrainian forces from one village, description of battle from Russian commander in paragraphs 1, 4-11, official visi
S

Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet beats profit estimates on strong demand for medical devices Aug 7 (Reuters) - Zimmer Biomet Holdings ZBH.N beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures. Medical device makers have boosted investor expectations in the recent quarters as more people, especially older Americans, opt for non-urgent surgeries such as hip and knee replacements.
S
Z

Baxter raises full-year profit forecast on robust demand for medical devices

Baxter raises full-year profit forecast on robust demand for medical devices Aug 6 (Reuters) - Baxter International BAX.N on Tuesday raised its annual profit expectations and beat Wall Street estimates for second-quarter profit on strong sales of its medical devices, driven by robust demand for medical care among patients. Shares of the company rose 3% to $35.69 in premarket trading.
S

Teleflex raises 2024 profit forecast on medical device demand

Teleflex raises 2024 profit forecast on medical device demand Aug 1 (Reuters) - Surgical equipment maker Teleflex TFX.N raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals to drive sales for its medical devices. The company also said its board authorized a share repurchase program for up to $500 million of common stock.
S
T



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.